首页 | 本学科首页   官方微博 | 高级检索  
     

人IL—18结合蛋白cDNA的克隆及其逆转录病毒载体的构建
引用本文:傅奕,赵惠仁,陆梁. 人IL—18结合蛋白cDNA的克隆及其逆转录病毒载体的构建[J]. 徐州医学院学报, 2001, 21(4): 313-316
作者姓名:傅奕  赵惠仁  陆梁
作者单位:徐州医学院生物化学与分子生物学研究中心,
基金项目:江苏省教育厅自然科学基金资助课题(00KJB310008)
摘    要:目的:克隆人白细胞介素-18结合蛋白(hIL-18BP)的cDNA及构建hIL-18BP逆转录病毒载体,以研究IL-18BP与IL-18相互作用的机制及自身免疫性疾病的基因治疗。方法:从中国汉族人胎盘组织中提取总RNA,用RT-PCR方法扩增hIL-18BP cDNA,与载体pcDNA3连接,转化大肠杆菌DH5α,得到的重组质粒经鉴定正确后,再作为模板进行PCR,PCR产物插入逆转录病毒载体pLNCX中。结果RT-PCR扩增出全长585bp hIL-18BP cDNA,2次酶切鉴定证明hIL-18BP已分别与pcDNA3,pLNCX重组,2次测序结果均与国外文献报道的hIL-18BP的序列一致。结论:成功地克隆了中国人IL-18BP cDNA,并构建了重组hIL-18BP 闻转录病毒载体。

关 键 词:白细胞介素-18结合蛋白 克隆 逆转录病毒载体
文章编号:1000-2065(2001)04-0313-04

Cloning of human interleukdn- 18 binding protein and the construction of its retroviral vector
FU Yi,ZHAO Hui-ren,LU Liang. Cloning of human interleukdn- 18 binding protein and the construction of its retroviral vector[J]. Acta Academiae Medicinae Xuzhou, 2001, 21(4): 313-316
Authors:FU Yi  ZHAO Hui-ren  LU Liang
Abstract:Objective To clone the cDNA of human interleukin-18 binding protein (hIL-18BP) and construct the recombined hIL-18BP retrovirus as a theoretical and preparatory approach to the IL-18BP gene therapy for autoimmune diseases. Methods The total RNA was extracted from the placenta of a Chinese individual and the intact cDNA of hIL-18BP was amplified by RT-PCR. The cDNA obtained was first linked with pcDNA3 vector and then transferred into E.coli DH5(. After being identified, the recombined plasmid (pcDNA3/ hIL-18BP) was used as the template in PCR, and finally, the 585 bp PCR product was inserted into the retroviral vector pLNCX. Results Recombined pcDNA3/ hIL-18BP, pLNCX/ hIL-18BP were identified by double-enzyme digestion and the results of sequencing were consistent with that of the published hIL-18BP cDNA. Conclusion Chinese IL-18BP cDNA has been cloned and the recombined hIL-18BP retroviral vector has been constructed successfully.
Keywords:interleukin-18 binding protein  clone  retroviral vector
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号